Kristina M. Feye
- Courses2
- Reviews3
- School: Des Moines Area Community College
- Campus:
- Department: Biology
- Email address: Join to see
- Phone: Join to see
-
Location:
1100 7th St
Ankeny, IA - 50314 - Dates at Des Moines Area Community College: May 2016 - October 2016
- Office Hours: Join to see
Biography
Des Moines Area Community College - Biology
Scientist ~ Molecular Biologist ~ Microbiologist
Kristina
Feye, M.S., Ph.D.
Greater Milwaukee Area
I am an experienced research microbiologist and molecular biologist with a demonstrated history of working in the government, private, and academic sectors. I have a strong research background and earned a Doctor of Philosophy (Ph.D.) focused in Biomedical Sciences, Major Pharmacology from Iowa State University in 2017. I love my field and am looking forward to connecting!
Experience
Waseen, Inc.
Research And Development Manager
Kristina worked at Waseen, Inc. as a Research And Development Manager
Des Moines Area Community College
Adjunct Faculty Instructor of Biology
Kristina worked at Des Moines Area Community College as a Adjunct Faculty Instructor of Biology
Stephen F. Austin State University
Graduate Research And Teaching Assistant
Evaluating road kill for parasites, elucidating the FABP in Cryptosporidium parvum, acting as interim Laboratory Teaching lead
Texas Woman's University
Undergraduate Research Assistant
Volunteer/for credit undergraduate research assistant
SeqWright
Laboratory Technician
Kristina worked at SeqWright as a Laboratory Technician
Iowa State University
Graduate Research Assistant
Kristina worked at Iowa State University as a Graduate Research Assistant
US Department of Agriculture (USDA) Agricultural Research Service (ARS)
Research Microbiologist
Kristina worked at US Department of Agriculture (USDA) Agricultural Research Service (ARS) as a Research Microbiologist
Self Employed
Independent Consultant
Kristina worked at Self Employed as a Independent Consultant
University of Arkansas
Postdoctoral Researcher
Kristina worked at University of Arkansas as a Postdoctoral Researcher
University of Arkansas
Adjunct Assistant Professor
Kristina worked at University of Arkansas as a Adjunct Assistant Professor
Publications
Abrogation of Salmonella and E. coli O157:H7 in Feedlot Cattle Fed a Proprietary Saccharomyces cerevisiae Fermentation Prototype
Journal of Veterinary Science and Technology
T (n=747 heifers) or the standard industry diet (PC; n=748 heifers) without PRT for 125-146 days prior to slaughter. At the abattoir, fecal swabs were obtained from 400 animals (n=200/group) and subjected to selective culture for enumerating Salmonella and E. coli O157:H7. Additionally, subiliac lymph nodes were obtained from 400 carcasses for enumeration of Salmonella spp. Salmonella isolated from the feces and lymph nodes were subjected to a virulence assay and some antibiotic susceptibility and Salmonella serovar testing. When compared to cattle that received PC, Salmonella fecal shedding, lymph node infiltration, virulence, and antibiotic resistances were significantly decreased in cattle fed PRT. Additionally, PRT-fed cattle had a lower prevalence of certain Salmonella serovars (Newport, Typhimurium, and Dublin) and shed fewer E. coli O157:H7. The decrease in Salmonella virulence was associated with a decreased expression of hilA, a genetic regulator of Salmonella invasion into eukaryotic cells. This study revealed that a proprietary Saccharomyces cerevisiae fermentation prototype inhibits the shedding, lymph node carriage, downstream virulence, and antibiotic resistance of Salmonella residing in cattle beyond the standard conventional practice that includes monensin, tylosin, and a direct-fed microbial. 
Abrogation of Salmonella and E. coli O157:H7 in Feedlot Cattle Fed a Proprietary Saccharomyces cerevisiae Fermentation Prototype
Journal of Veterinary Science and Technology
T (n=747 heifers) or the standard industry diet (PC; n=748 heifers) without PRT for 125-146 days prior to slaughter. At the abattoir, fecal swabs were obtained from 400 animals (n=200/group) and subjected to selective culture for enumerating Salmonella and E. coli O157:H7. Additionally, subiliac lymph nodes were obtained from 400 carcasses for enumeration of Salmonella spp. Salmonella isolated from the feces and lymph nodes were subjected to a virulence assay and some antibiotic susceptibility and Salmonella serovar testing. When compared to cattle that received PC, Salmonella fecal shedding, lymph node infiltration, virulence, and antibiotic resistances were significantly decreased in cattle fed PRT. Additionally, PRT-fed cattle had a lower prevalence of certain Salmonella serovars (Newport, Typhimurium, and Dublin) and shed fewer E. coli O157:H7. The decrease in Salmonella virulence was associated with a decreased expression of hilA, a genetic regulator of Salmonella invasion into eukaryotic cells. This study revealed that a proprietary Saccharomyces cerevisiae fermentation prototype inhibits the shedding, lymph node carriage, downstream virulence, and antibiotic resistance of Salmonella residing in cattle beyond the standard conventional practice that includes monensin, tylosin, and a direct-fed microbial. 
Inhibition of the virulence, antibiotic resistance, and fecal shedding of multiple antibiotic-resistant Salmonella Typhimurium in broilers fed Original XPC™
Poultry Science
Salmonella carriage is an insidious problem for the poultry industry. While most Salmonella serotypes are avirulent in poultry, these bacteria can contaminate chicken meat during processing, leading to one of the most important food safety hazards. In this study, we examined the anti-Salmonella effects of Diamond V Original XPC™ (XPC) included in the finisher diet fed to commercial broilers. On 3 occasions between day one (D1) and D20, broilers were experimentally infected with multiple antibiotic-resistant Salmonella Typhimurium. After confirming that the chicks were shedding Salmonella in the feces on D21, broiler chicks were fed a diet containing XPC (n = 57 birds; 1.25 kg/MT) or an XPC-free control diet (CON) (n = 57 birds) to D49. Fecal samples were obtained weekly and subjected to selective culture for enumerating and determining the antibiotic resistance of the Salmonella. Salmonella isolates were then subjected to an in vitro virulence assay, which predicts the ability of Salmonella to cause illness in a mammalian host. Broilers were euthanized on D49 and a segment of the large intestine was removed and subjected to the same assays used for the fecal samples. When compared to the birds fed the CON diet, Salmonella fecal shedding, virulence (invasion and invasion gene expression), and antibiotic resistance were significantly decreased in birds fed XPC (5-fold, 7.5-fold, 6-fold, and 5.3-fold decreases, respectively). Birds fed XPC exhibited heavier body weight (BW) and greater BW gains than those fed the CON diet. The decrease in virulence was associated with a decreased expression of a genetic regulator of Salmonella invasion into cells (hilA), while the decrease in antibiotic resistance was due to a loss of an integron (SGI1) from the input strain. This study revealed that Original XPC™ inhibits the shedding, downstream virulence, and antibiotic resistance of Salmonella residing in broilers.
Abrogation of Salmonella and E. coli O157:H7 in Feedlot Cattle Fed a Proprietary Saccharomyces cerevisiae Fermentation Prototype
Journal of Veterinary Science and Technology
T (n=747 heifers) or the standard industry diet (PC; n=748 heifers) without PRT for 125-146 days prior to slaughter. At the abattoir, fecal swabs were obtained from 400 animals (n=200/group) and subjected to selective culture for enumerating Salmonella and E. coli O157:H7. Additionally, subiliac lymph nodes were obtained from 400 carcasses for enumeration of Salmonella spp. Salmonella isolated from the feces and lymph nodes were subjected to a virulence assay and some antibiotic susceptibility and Salmonella serovar testing. When compared to cattle that received PC, Salmonella fecal shedding, lymph node infiltration, virulence, and antibiotic resistances were significantly decreased in cattle fed PRT. Additionally, PRT-fed cattle had a lower prevalence of certain Salmonella serovars (Newport, Typhimurium, and Dublin) and shed fewer E. coli O157:H7. The decrease in Salmonella virulence was associated with a decreased expression of hilA, a genetic regulator of Salmonella invasion into eukaryotic cells. This study revealed that a proprietary Saccharomyces cerevisiae fermentation prototype inhibits the shedding, lymph node carriage, downstream virulence, and antibiotic resistance of Salmonella residing in cattle beyond the standard conventional practice that includes monensin, tylosin, and a direct-fed microbial. 
Inhibition of the virulence, antibiotic resistance, and fecal shedding of multiple antibiotic-resistant Salmonella Typhimurium in broilers fed Original XPC™
Poultry Science
Salmonella carriage is an insidious problem for the poultry industry. While most Salmonella serotypes are avirulent in poultry, these bacteria can contaminate chicken meat during processing, leading to one of the most important food safety hazards. In this study, we examined the anti-Salmonella effects of Diamond V Original XPC™ (XPC) included in the finisher diet fed to commercial broilers. On 3 occasions between day one (D1) and D20, broilers were experimentally infected with multiple antibiotic-resistant Salmonella Typhimurium. After confirming that the chicks were shedding Salmonella in the feces on D21, broiler chicks were fed a diet containing XPC (n = 57 birds; 1.25 kg/MT) or an XPC-free control diet (CON) (n = 57 birds) to D49. Fecal samples were obtained weekly and subjected to selective culture for enumerating and determining the antibiotic resistance of the Salmonella. Salmonella isolates were then subjected to an in vitro virulence assay, which predicts the ability of Salmonella to cause illness in a mammalian host. Broilers were euthanized on D49 and a segment of the large intestine was removed and subjected to the same assays used for the fecal samples. When compared to the birds fed the CON diet, Salmonella fecal shedding, virulence (invasion and invasion gene expression), and antibiotic resistance were significantly decreased in birds fed XPC (5-fold, 7.5-fold, 6-fold, and 5.3-fold decreases, respectively). Birds fed XPC exhibited heavier body weight (BW) and greater BW gains than those fed the CON diet. The decrease in virulence was associated with a decreased expression of a genetic regulator of Salmonella invasion into cells (hilA), while the decrease in antibiotic resistance was due to a loss of an integron (SGI1) from the input strain. This study revealed that Original XPC™ inhibits the shedding, downstream virulence, and antibiotic resistance of Salmonella residing in broilers.
Theoretical Engineering of the Gut Microbiome for the Purpose of Creating Superior Soldiers
Research & Reviews: Journal of Medical and Health Sciences
The purpose of this review is to highlight research raising the possibility of exploiting the host-microbiome gut axis for military purposes. Through optimizing the gut-microbiome environment it is possible to enhance nutritional access to indigestible material, provide local and systemic analgesia, enhance psychological robustness to battlefield stress, produce endogenous steroids, reduce muscle fatigue, and promote peripheral wound healing. However, this approach is still in its early stages and thus has not been explored to its full potential. The challenges that are currently preventing the practical use of gut- bacteria include the following: inconsistency of clinical outcomes, transient effects requiring continuous supplementation, the type of regimen selected, the initiation and cessation of regimen, and the broader clinical studies needed to validate this research. This review is intended to shed light on the numerous and varied positive impacts such an approach could have for the military if further developed.
Abrogation of Salmonella and E. coli O157:H7 in Feedlot Cattle Fed a Proprietary Saccharomyces cerevisiae Fermentation Prototype
Journal of Veterinary Science and Technology
T (n=747 heifers) or the standard industry diet (PC; n=748 heifers) without PRT for 125-146 days prior to slaughter. At the abattoir, fecal swabs were obtained from 400 animals (n=200/group) and subjected to selective culture for enumerating Salmonella and E. coli O157:H7. Additionally, subiliac lymph nodes were obtained from 400 carcasses for enumeration of Salmonella spp. Salmonella isolated from the feces and lymph nodes were subjected to a virulence assay and some antibiotic susceptibility and Salmonella serovar testing. When compared to cattle that received PC, Salmonella fecal shedding, lymph node infiltration, virulence, and antibiotic resistances were significantly decreased in cattle fed PRT. Additionally, PRT-fed cattle had a lower prevalence of certain Salmonella serovars (Newport, Typhimurium, and Dublin) and shed fewer E. coli O157:H7. The decrease in Salmonella virulence was associated with a decreased expression of hilA, a genetic regulator of Salmonella invasion into eukaryotic cells. This study revealed that a proprietary Saccharomyces cerevisiae fermentation prototype inhibits the shedding, lymph node carriage, downstream virulence, and antibiotic resistance of Salmonella residing in cattle beyond the standard conventional practice that includes monensin, tylosin, and a direct-fed microbial. 
Inhibition of the virulence, antibiotic resistance, and fecal shedding of multiple antibiotic-resistant Salmonella Typhimurium in broilers fed Original XPC™
Poultry Science
Salmonella carriage is an insidious problem for the poultry industry. While most Salmonella serotypes are avirulent in poultry, these bacteria can contaminate chicken meat during processing, leading to one of the most important food safety hazards. In this study, we examined the anti-Salmonella effects of Diamond V Original XPC™ (XPC) included in the finisher diet fed to commercial broilers. On 3 occasions between day one (D1) and D20, broilers were experimentally infected with multiple antibiotic-resistant Salmonella Typhimurium. After confirming that the chicks were shedding Salmonella in the feces on D21, broiler chicks were fed a diet containing XPC (n = 57 birds; 1.25 kg/MT) or an XPC-free control diet (CON) (n = 57 birds) to D49. Fecal samples were obtained weekly and subjected to selective culture for enumerating and determining the antibiotic resistance of the Salmonella. Salmonella isolates were then subjected to an in vitro virulence assay, which predicts the ability of Salmonella to cause illness in a mammalian host. Broilers were euthanized on D49 and a segment of the large intestine was removed and subjected to the same assays used for the fecal samples. When compared to the birds fed the CON diet, Salmonella fecal shedding, virulence (invasion and invasion gene expression), and antibiotic resistance were significantly decreased in birds fed XPC (5-fold, 7.5-fold, 6-fold, and 5.3-fold decreases, respectively). Birds fed XPC exhibited heavier body weight (BW) and greater BW gains than those fed the CON diet. The decrease in virulence was associated with a decreased expression of a genetic regulator of Salmonella invasion into cells (hilA), while the decrease in antibiotic resistance was due to a loss of an integron (SGI1) from the input strain. This study revealed that Original XPC™ inhibits the shedding, downstream virulence, and antibiotic resistance of Salmonella residing in broilers.
Theoretical Engineering of the Gut Microbiome for the Purpose of Creating Superior Soldiers
Research & Reviews: Journal of Medical and Health Sciences
The purpose of this review is to highlight research raising the possibility of exploiting the host-microbiome gut axis for military purposes. Through optimizing the gut-microbiome environment it is possible to enhance nutritional access to indigestible material, provide local and systemic analgesia, enhance psychological robustness to battlefield stress, produce endogenous steroids, reduce muscle fatigue, and promote peripheral wound healing. However, this approach is still in its early stages and thus has not been explored to its full potential. The challenges that are currently preventing the practical use of gut- bacteria include the following: inconsistency of clinical outcomes, transient effects requiring continuous supplementation, the type of regimen selected, the initiation and cessation of regimen, and the broader clinical studies needed to validate this research. This review is intended to shed light on the numerous and varied positive impacts such an approach could have for the military if further developed.
Off-Target drug effects resulting in altered gene expression events with epigenetic and quasi-epigenetic⿿ origins
Pharmacological Research
This review synthesizes examples of pharmacological agents who have off-target effects of an epigenetic nature. We expand upon the paradigm of epigenetics to include ⿿quasi-epigenetic⿿ mechanisms. Quasi-epigenetics includes mechanisms of drugs acting upstream of epigenetic machinery or may themselves impact transcription factor regulation on a more global scale. We explore these avenues with four examples of conventional pharmaceuticals and their unintended, but not necessarily adverse, biological effects. The quasi-epigenetic drugs identified in this review include the use of beta-lactam antibiotics to alter glutamate receptor activity and the action of cyclosporine on multiple transcription factors. In addition, we report on more canonical epigenome changes associated with pharmacological agents such as lithium impacting autophagy of aberrant proteins, and opioid drugs whose chronic use increases the expression of genes associated with addictive phenotypes. By expanding our appreciation of transcriptomic regulation and the effects these drugs have on the epigenome, it is possible to enhance therapeutic applications by exploiting off-target effects and even repurposing established pharmaceuticals. That is, exploration of ⿿pharmacoepigenetic⿿ mechanisms can expand the breadth of the useful activity of a drug beyond the traditional drug targets such as receptors and enzymes.
